Comparison of Postdoctoral Pharmacy Training Programs: Drug Information Residencies and Medical Information Fellowships

被引:0
作者
Jimmy Gonzalez
Samantha Bryant
Michael Hogan
Sandra Bai
Lesley Fierro
Evelyn R. Hermes-DeSantis
机构
[1] Western New England University,College of Pharmacy and Health Sciences
[2] Cooley Dickinson Hospital,Ernest Mario School of Pharmacy
[3] Rutgers University,undefined
[4] Purdue University College of Pharmacy,undefined
[5] Robert Wood Johnson University Hospital,undefined
[6] Department of Pharmacy Practice and Administration,undefined
来源
Therapeutic Innovation & Regulatory Science | 2019年 / 53卷
关键词
medical information; drug information; postgraduate pharmacy training; residency; fellowship;
D O I
暂无
中图分类号
学科分类号
摘要
Pharmacy graduates interested in postdoctoral training opportunities in drug information or Medical Information have the option to pursue either a fellowship within the pharmaceutical industry or a clinical residency. Limited resources exist for pharmacy students to gain insight into the differences between drug information (DI) and medical information (MI) training programs. The purpose of this project is to identify available opportunities for postdoctoral training in DI or MI disciplines and to identify similarities and differences between them. DI residencies and MI fellowships were identified by examination of the American Society of Health-System Pharmacists (ASHP) and the American College of Clinical Pharmacy (ACCP) residency directories, the ASHP Personal Placement Service (PPS) index, and online keyword searching for nonindexed programs. The authors investigated individual programs via publicly available information to classify core responsibilities and skill sets developed; a total of 24 DI residency programs and 33 MI fellowships focusing or containing at least 1 component in medical information were evaluated. All ASHP-accredited DI residencies offered teaching, formulary management, adverse drug reaction and medication error reporting, drug utilization evaluation, and policy development as professional growth opportunities. The most commonly encountered development activities in MI fellowships were creating standard response documents, collaborating with cross functional teams, teaching or precepting, and reviewing promotional materials. Institutions and health care providers (HCPs) are the primary recipients of DI services whereas MI services respond to consumers, payors, HCPs, and external organizations. Employment prospects commonly overlap between the 2 training programs.
引用
收藏
页码:446 / 454
页数:8
相关论文
共 30 条
  • [1] Thompson DF(2006)A personal view of the history and future direction of drug information Ann Pharmacother 40 307-308
  • [2] Walton CA(1966)Education and training of the drug information specialist Drug Intell 1 132-137
  • [3] Rosenberg JM(2009)Update on the status of 89 drug information centers in the United States Am J Health Syst Pharm 66 1718-1722
  • [4] Schilit S(2010)The mandatory residency dilemma: parallels to historical transitions in pharmacy education Ann Pharmacother 44 1793-1799
  • [5] Nathan JP(1987)Definitions of pharmacy residencies and fellowships Am J Hosp Pharm 44 1142-1144
  • [6] Bright DR(2014)Celebrating 50 years of advancement in pharmacy residency training Am J Health Syst Pharm 71 1190-1195
  • [7] Adams AJ(2012)Postdoctoral pharmacy industry fellowships: a descriptive analysis of programs and postgraduate positions Am J Health Syst Pharm 69 63-68
  • [8] Black CD(2015)Ten steps for setting up an online journal club J Contin Educ Health Prof 35 148-154
  • [9] Powers MF(2015)ASHP guidelines on the pharmacist’s role in providing drug information Am J Health Syst Pharm 72 573-577
  • [10] Clark T(2010)Utility and value of a medicines information service provided by pharmacists: a survey of health professionals Int J Pharm Pract 18 353-361